# Development and Physicochemical Characterisation of Probiotic Emulsions Containing Lactobacillus rhamnosus for Potential Dermal Applications

**Authors:** Monika Gasztych, Ruth Dudek-Wicher, Dawid Brzozowski, Arleta Dołowacka-Jóźwiak, Witold Musiał

PMC · DOI: 10.3390/pharmaceutics18020199 · 2026-02-03

## TL;DR

This study explores how different emulsion compositions affect the survival and stability of Lactobacillus rhamnosus GG in formulations for potential skin applications.

## Contribution

The study introduces a method to optimize probiotic emulsions for dermal use by analyzing their physicochemical properties and bacterial viability.

## Key findings

- An emulsion pH of 4.65 supports Lactobacillus rhamnosus GG survival, aligning with human skin acidity.
- FTIR analysis confirmed structural stability and spectral shifts due to bacterial presence.
- All emulsions were O/W systems, supporting bacterial viability and suitability for topical use.

## Abstract

Background/Objectives: This study evaluated how variations in emulsion composition influence the viability of a probiotic strain Lactobacillus rhamnosus GG within biphasic systems, as well as the overall stability of the resulting formulations. Methods: Eight biphasic emulsions were prepared, each in two versions—with and without a preservative—and subsequently analysed for pH, FTIR spectroscopy, and emulsion type. The viability of L. rhamnosus GG in each formulation was determined using the plate count method. This method is regarded as the reference technique for the quantitative determination of viable bacteria, expressed as colony-forming units (CFUs). Results: The pH indicated that an emulsion with a pH of 4.65 provides the most favorable conditions for L. rhamnosus GG survival, as values below pH 6 promote its proliferation. This acidity aligns with the natural pH of human skin, although it falls slightly below the recommended 4–5 range for topical formulations. FTIR analysis confirmed the structural stability of the emulsions and revealed spectral shifts attributable to the presence of the bacteria. The spectra remained largely consistent throughout the study period, demonstrating good temporal stability. Conclusions: Microbiological evaluation showed that all produced formulations supported bacterial growth, the presence of the preservative did not inhibit viability of L. rhamnosus GG, corroborating findings from an independent assessment. All emulsions were classified as O/W systems, due to the high water content which is advantageous for microbial viability. Furthermore, O/W emulsions are user-friendly, easy to remove, limit the penetration of the active component into deeper skin layers, supporting their suitability for probiotic-based topical applications.

## Full-text entities

- **Diseases:** psoriasis (MESH:D011565), skin disorders (MESH:D012871), rosacea (MESH:D012393), chronic inflammation (MESH:D007249), injury to (MESH:D014947), water (MESH:D000069578), Dysbiosis (MESH:D064806), fungal (MESH:D009181), AD (MESH:D003876), acne vulgaris (MESH:D000152), erythema (MESH:D004890), seborrheic dermatitis (MESH:D012628), eczema (MESH:D004485), dermatological disorders (MESH:D000168), gastrointestinal disorders (MESH:D005767)
- **Chemicals:** stearic acid (MESH:C031183), benzyl alcohol (MESH:D019905), alkenes (MESH:D000475), water (MESH:D014867), linseed oil (MESH:D008043), amide (MESH:D000577), silicone oil (MESH:D012827), ceramide (MESH:D002518), aldehydes (MESH:D000447), inulin (MESH:D007444), sugars (MESH:D000073893), 2,3,5-triphenyltetrazolium chloride (MESH:C009591), formazan (MESH:D005562), Sudan III (MESH:C033006), O (MESH:D010100), phenoxyethanol (MESH:C005398), saline (MESH:D012965), ketones (MESH:D007659), agar (MESH:D000362), esters (MESH:D004952), sweet almond oil (MESH:C068582), lactic acid (MESH:D019344), polysaccharide (MESH:D011134), lipid (MESH:D008055), W (MESH:D014414), potassium sorbate (MESH:D013011), CO2 (MESH:D002245), biobase (MESH:C485828), DHA (MESH:C027493), beta glucan (MESH:D047071), glyceryl monostearate (MESH:C048159), methyl orange (MESH:C100258), K (MESH:D011188), Em (MESH:D004961), oximes (MESH:D010091), imines (MESH:D007097), glycerin (MESH:D005990), dimethicone (MESH:C501844), DHA BA (-), carnauba wax (MESH:C026344), propylene glycol (MESH:D019946), Cetyl alcohol (MESH:C005031), fatty acids (MESH:D005227), oil (MESH:D009821), carbohydrate (MESH:D002241)
- **Species:** Lactobacillus acidophilus (species) [taxon 1579], Cutibacterium acnes (species) [taxon 1747], Lacticaseibacillus rhamnosus GG (strain) [taxon 568703], Lacticaseibacillus rhamnosus (species) [taxon 47715], Lactobacillus delbrueckii subsp. bulgaricus (subspecies) [taxon 1585], Levilactobacillus brevis (species) [taxon 1580], Lacticaseibacillus casei (species) [taxon 1582], Homo sapiens (human, species) [taxon 9606], Staphylococcus epidermidis (species) [taxon 1282], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395]
- **Mutations:** X 1000D

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944043/full.md

---
Source: https://tomesphere.com/paper/PMC12944043